Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

Publication Detail

Title: Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD.

Authors: Lemoine S, Chantal M; Brigham, Emily P; Woo, Han; Hanson, Corrine K; McCormack, Meredith C; Koch, Abigail; Putcha, Nirupama; Hansel, Nadia N

Published In BMC Pulm Med, (2019 05 21)

Abstract: Omega-3 fatty acids, including alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and derivatives, play a key role in the resolution of inflammation. Higher intake has been linked to decreased morbidity in several diseases, though effects on respiratory diseases like COPD are understudied.The National Health and Nutrition Examination Survey (NHANES), with a focus on dietary assessment, provides a unique opportunity to explore relationships between omega-3 intake and morbidity in respiratory diseases marked by inflammation in the United States (US) population. We investigated relationships between ALA or EPA + DHA intake and respiratory symptoms among US adults with COPD, as well as variation in relationships based on personal characteristics or exposures.Of 878 participants, mean age was 60.6 years, 48% were current smokers, and 68% completed high school. Omega-3 intake was, 1.71 ± 0.89 g (ALA), and 0.11 ± 0.21 g (EPA + DHA). Logistic regression models, adjusting for age, gender, race, body mass index, FEV1, education, smoking status, pack-years, total caloric intake, and omega-6 (linoleic acid, LA) intake demonstrated no primary associations between omega-3 intake and respiratory symptoms. Interaction terms were used to determine potential modification of relationships by personal characteristics (race, gender, education) or exposures (LA intake, smoking status), demonstrating that at lower levels of LA intake, increasing ALA intake was associated with reduced odds of chronic cough (pint = 0.015) and wheeze (pint = 0.037). EPA + DHA, but not ALA, was associated with reduced symptoms only among current smokers who did not complete high school.Individual factors should be taken into consideration when studying the association of fatty acid intake on respiratory diseases, as differential responses may reveal susceptible subgroups.

PubMed ID: 31122230 Exiting the NIEHS site

MeSH Terms: Aged; Cough/drug therapy*; Cough/epidemiology; Cross-Sectional Studies; Dietary Supplements*; Docosahexaenoic Acids/administration & dosage; Eicosapentaenoic Acid/administration & dosage; Eicosapentaenoic Acid/analogs & derivatives; Fatty Acids, Omega-3/administration & dosage*; Female; Humans; Logistic Models; Male; Middle Aged; Nutrition Surveys; Pulmonary Disease, Chronic Obstructive/drug therapy*; Pulmonary Disease, Chronic Obstructive/physiopathology*; Respiratory Function Tests; Respiratory Sounds/drug effects*; United States; alpha-Linolenic Acid/administration & dosage

to Top